CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 58 enrolled
Drug / intervention
combined spinal epiduraldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02020304
NCT02020304Phase 2Completed
CompareCT.gov

Effect of Temperature of Combined Spinal Epidural Dosing on Duration

Wake Forest University Health Sciences·interventional·Posted Dec 24, 2013·Updated Sep 10, 2018

In Brief

A Phase 2 clinical trial evaluating combined spinal epidural for Pain. Completed, enrolled 58 participants across 1 site.

Detailed Summary

The hypothesis is that a combined spinal-epidural drug at refrigerated temperature will have a shorter period of pain relief than that maintained at room temperature. The temperature of the dose of medication will be measure with an infrared thermometer immediately prior (within 5 minutes) to administration.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 24, 2013
Enrollment StartAug 29, 2013
Primary CompletionMay 4, 2014
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.5 years ago

Interventions

combined spinal epiduraldrug

Combined Spinal Epidural